Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMLN (DIABETES DRUGS) -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (1373)	5/16/1998 4:34:00 PM
From: jbershad	Read Replies (1) \| Respond to of 2173

To all One thing overlooked is the fact that J&J has more than 10% of the outstanding shares of AMLN. There are also many funds and institutions that hold much more. To date I have not found anybody with announced intentions to sell. Mike Murphy has rated AMLN one his best buys, he expects LLY to take over sooner rather than later. The FDA is now allowing phase 4 studies for certain drugs for AIDS and cancer. The drug is marketed and and studies are continued. A cooperative FDA and congress. An understanding of how difficult these drug studies are? Wow. Jerry